Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 753

Results: 6

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.ado2817
By:
- Cai, Yingyun;
- Diallo, Seme;
- Rosenthal, Kim;
- Ren, Kuishu;
- Flores, Daniel J.;
- Dippel, Andrew;
- Oganesyan, Vaheh;
- van Dyk, Nydia;
- Chen, Xiaoru;
- Cantu, Erin;
- Choudhary, Rakesh;
- Sulikowski, Michal;
- Adissu, Hibret;
- Chawla, Bhavna;
- Kar, Swagata;
- Liu, Chang;
- Dijokaite-Guraliuc, Aiste;
- Mongkolsapaya, Juthathip;
- Rajan, Saravanan;
- Loo, Yueh-Ming
Publication type:
Article
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.adn3504
By:
- Dammer, Eric B.;
- Shantaraman, Anantharaman;
- Ping, Lingyan;
- Duong, Duc M.;
- Gerasimov, Ekaterina S.;
- Ravindran, Suda Parimala;
- Gudmundsdottir, Valborg;
- Frick, Elisabet A.;
- Gomez, Gabriela T.;
- Walker, Keenan A.;
- Emilsson, Valur;
- Jennings, Lori L.;
- Gudnason, Vilmundur;
- Western, Daniel;
- Cruchaga, Carlos;
- Lah, James J.;
- Wingo, Thomas S.;
- Wingo, Aliza P.;
- Seyfried, Nicholas T.;
- Levey, Allan I.
Publication type:
Article
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.adl3758
By:
- Pluvinage, John V.;
- Ngo, Thomas;
- Fouassier, Camille;
- McDonagh, Maura;
- Holmes, Brandon B.;
- Bartley, Christopher M.;
- Kondapavulur, Sravani;
- Hurabielle, Charlotte;
- Bodansky, Aaron;
- Pai, Vincent;
- Hinman, Sam;
- Aslanpour, Ava;
- Alvarenga, Bonny D.;
- Zorn, Kelsey C.;
- Zamecnik, Colin;
- McCann, Adrian;
- Asencor, Andoni I.;
- Huynh, Trung;
- Browne, Weston;
- Tubati, Asritha
Publication type:
Article
New government drug repurposing programs: Opportunities and uncertainties.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.adl0998
By:
- Liddicoat, Johnathon;
- Hamidzadeh, Ashleigh;
- Liddell, Kathleen;
- Schito, Marco;
- Simon, David;
- Aboy, Mateo;
- Minssen, Timo
Publication type:
Article
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.adk0330
By:
- Zhang, Hai-Liang;
- Hu, Bing-Xin;
- Ye, Zhi-Peng;
- Li, Zhi-Ling;
- Liu, Shan;
- Zhong, Wen-Qing;
- Du, Tian;
- Yang, Dong;
- Mai, Jia;
- Li, Li-Chao;
- Chen, Yu-Hong;
- Zhu, Xian-Ying;
- Li, Xuan;
- Feng, Gong-Kan;
- Zhu, Xiao-Feng;
- Deng, Rong
Publication type:
Article
MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells.
Published in:
Science Translational Medicine, 2024, v. 16, n. 753, p. 1, doi. 10.1126/scitranslmed.adj1597
By:
- Perrin, Simon;
- Protic, Sanela;
- Bretegnier, Vincent;
- Laurendeau, Ingrid;
- de Lageneste, Oriane Duchamp;
- Panara, Nicolas;
- Ruckebusch, Odile;
- Luka, Marine;
- Masson, Cécile;
- Maillard, Théodora;
- Coulpier, Fanny;
- Pannier, Stéphanie;
- Wicart, Philippe;
- Hadj-Rabia, Smail;
- Radomska, Katarzyna J.;
- Zarhrate, Mohammed;
- Ménager, Mickael;
- Vidaud, Dominique;
- Topilko, Piotr;
- Parfait, Béatrice
Publication type:
Article

Works matching IS 19466234 AND DT 2024 AND VI 16 AND IP 753

AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.

Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment.

Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.

New government drug repurposing programs: Opportunities and uncertainties.

TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer.

MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem/progenitor cells.